

Automated Cell Expansion System
自动化细胞扩增系统
- SKU CPR-0002
- Cell Processing
- CE (to be confirmed)
- ISO 13485 manufacturing (to be confirmed)
- 21 CFR Part 11 software documentation (to be confirmed)
Price on request — FOB / CIF quoted per order
Prices depend on configuration, quantity and destination port.
Key specifications
| Culture volume | 0.1–50 L |
|---|---|
| Fold expansion | Up to several hundred fold (cell dependent) |
| Temperature control | 35–39 °C, ±0.2 °C |
| Dissolved oxygen control | Adjustable setpoint |
| Feeding mode | Perfusion or periodic |
| Gas exchange | Membrane or gas-permeable bag |
By Lab Manufacturers China Technical TeamLast reviewed Standards: EU GMP Annex 1, EU GMP Annex 11, 21 CFR Part 11
What is the Automated Cell Expansion System?
An automated cell expansion system grows lymphocytes or other cells in a closed, controlled culture environment with defined feeding and gas exchange. It replaces multiple manual flask cultures in cell therapy manufacturing.
What is the Automated Cell Expansion System?
An automated cell expansion system grows lymphocytes or other cells in a closed, controlled culture environment with defined feeding and gas exchange. It replaces multiple manual flask cultures in cell therapy manufacturing.
Overview
An automated cell expansion system provides a controlled culture environment in a closed, usually single-use chamber. Cells and medium circulate through a gas-permeable membrane or a hollow-fibre network, or rest in a gas-permeable bag on a rocking platform, while the system regulates temperature, dissolved oxygen, pH and medium delivery. Perfusion or periodic feeding maintains nutrients and removes lactate and other metabolites, allowing high cell densities and large fold expansion from a small starting population. Reagents such as activation antibodies, cytokines or viral vectors are added at scheduled points through sterile connections. The system records vessel conditions, feed volumes and sampling events, and typically includes automated harvest at the end of the run. This reduces operator handling, open steps and variability compared with manual flask culture, which is important for autologous and allogeneic products.
How does it work?
Cell processing equipment manipulates living cells while preserving viability and function. Separation and selection use immunomagnetic beads or density gradients to enrich a target population. Activation with antibodies or cytokines prepares T cells or other lymphocytes for expansion, which is then carried out in closed, gas-permeable culture systems with controlled temperature, dissolved oxygen and feeding. Washing and concentration use centrifugation in a closed chamber or tangential flow filtration to remove medium, beads and impurities and to reach a defined dose volume. Formulation adds a cryoprotectant such as dimethyl sulfoxide before controlled-rate freezing stores the product at low temperature. Because the product is living and often autologous, the equipment is designed for closed processing, single-use fluid paths, low shear and full traceability of each patient batch.
What are the key features?
- Closed single-use culture chamber
- Automated control of temperature, oxygen and pH
- Perfusion or scheduled feeding with waste removal
- Scheduled reagent addition through sterile connections
- Automated harvest and process recording
What are the technical specifications?
A typical automated cell expansion system configuration offers culture volume of 0.1–50 L, fold expansion of Up to several hundred fold (cell dependent), temperature control of 35–39 °C, ±0.2 °C, dissolved oxygen control of Adjustable setpoint, feeding mode of Perfusion or periodic and gas exchange of Membrane or gas-permeable bag. Values are indicative of the product class; the exact figures for each configuration are confirmed on the quotation and the calibration documents supplied with the instrument.
Which applications is it used for?
The Automated Cell Expansion System is used in CAR-T and TCR cell manufacturing, T cell and NK cell expansion, allogeneic cell product production and regenerative medicine process development. Across the wider Cell Processing class, laboratories also deploy it for autologous cell therapy manufacturing, allogeneic cell product manufacturing and CAR-T and TCR cell production.
Which standards and certifications apply?
Relevant standards and methods include EU GMP Annex 1, EU GMP Annex 11, 21 CFR Part 11, 21 CFR Part 1271, ISO 13485, USP <1046> and IEC 61010-1. Certification candidates for this model are CE, ISO 13485 manufacturing and 21 CFR Part 11 software documentation; each is to be confirmed for the specific configuration before shipment, and certificates are supplied only where they have been issued.
Handle all materials under the appropriate biosafety and cleanroom conditions, and use aseptic technique throughout. Verify that reagents and consumables are qualified for the process and that lot changes are controlled. Confirm closed-system integrity, especially connectors and welds, and monitor cell counts, viability and sterility at defined points. Programmable steps should be locked and version controlled, and each patient or batch record should capture operator, reagents and deviations. Maintain temperature control and check that shear and centrifugation settings do not reduce viability. For regulated production, validate the process, qualify the equipment and confirm that software meets data integrity requirements. Electrical safety follows IEC 61010-1.
How do I select the right Automated Cell Expansion System?
Choose an automated expansion system when you need reproducible, closed culture at scale. In an RFQ specify culture volume range, expected fold expansion, feeding and perfusion options, gas exchange design, reagent addition ports, harvest method and data recording.
How does it compare with other Cell Processing variants?
Select equipment from the cell type, the target dose and the closedness your product requires. Autologous therapies need single-use, closed fluid paths that avoid open manipulation, so specify bag and connector formats and whether processing is manual, semi-automated or fully automated. For selection, choose immunomagnetic or density-based methods according to the required purity, recovery and whether the target is rare. For expansion, match the culture surface area, gas exchange and feeding strategy to the expected fold expansion and cell density. For washing and concentration, define the final dose volume, acceptable recovery and whether a cryoprotectant must be added in the same closed circuit. Confirm traceability, batch records and validation support, and check that the system fits your cleanroom grade and operator workflow.
Full specifications
| Culture volume | 0.1–50 L |
|---|---|
| Fold expansion | Up to several hundred fold (cell dependent) |
| Temperature control | 35–39 °C, ±0.2 °C |
| Dissolved oxygen control | Adjustable setpoint |
| Feeding mode | Perfusion or periodic |
| Gas exchange | Membrane or gas-permeable bag |
| Fluid path | Closed, single-use |
| Control platform | Automated with data logging and audit trail |
Indicative values for this product class. Final specifications are confirmed on the quotation and in the calibration documents supplied with the instrument.
Applications
- CAR-T and TCR cell manufacturing
- T cell and NK cell expansion
- Allogeneic cell product production
- Regenerative medicine process development
Key features
- Closed single-use culture chamber
- Automated control of temperature, oxygen and pH
- Perfusion or scheduled feeding with waste removal
- Scheduled reagent addition through sterile connections
- Automated harvest and process recording
Frequently asked questions about Automated Cell Expansion System
Fold expansion depends strongly on the cell type and starting material, ranging from a few fold to several hundred fold over one to two weeks. Perfusion feeding and controlled oxygen usually support higher densities and expansion than static culture.
Activation antibodies, cytokines or vectors are added at scheduled points through sterile connections, often automatically from reagent bags on the instrument. Volumes and times are logged, and closed connectors keep the culture isolated without opening the system.
Yes, closed single-use designs are intended for one patient per run, which limits cross-contamination between batches. Each run uses a new fluid path and records the patient identifier, so parallel processing of multiple autologous products remains traceable.
It manufactures cell-based products by selecting, activating, expanding, washing, concentrating, formulating and freezing cells. It is used in cell therapy production, stem cell processing and regenerative medicine, where closed, documented handling preserves viability and meets quality requirements.
Cell therapy products are living and often autologous, so open handling risks contamination and mix-ups between patients. Closed processing with single-use bags and aseptic connectors keeps the product isolated from the environment and from other batches, which is central to both safety and traceability.
Targets depend on the product and route of administration, but cell therapies commonly require high post-thaw viability, often above 70 to 80 percent, and defined recovery of the target population. Shear, temperature excursions, cryoprotectant exposure and hold times all affect these values.
Related models






